NCT06362369 2025-09-17A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT07010692 2025-09-17Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentBruce Robinson, MDPhase 1/2 Recruiting100 enrolled
NCT02836548 2025-07-10HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced MelanomaThe Netherlands Cancer InstitutePhase 1/2 Completed33 enrolled